Cancer Research and Treatment10.4143/crt.2019.3132020522438-445Loss of Heterozygosity at Chromosome 16q Is a Negative Prognostic Factor in Korean Pediatric Patients with Favorable Histology Wilms Tumor: A Report of the Korean Pediatric Hematology Oncology Group (K-PHOG)Jun Eun Park, O Kyu Noh, Yonghee Lee, Hyoung Soo Choi, Jung Woo Han, Seung Min Hahn, Chuhl Joo Lyu, Ji Won Lee, Keon Hee Yoo, Hong Hoe Koo, Seon-Yong Jeong, Ki Woong Sung,,
Journal of Pediatric Surgery10.1016/0022-3468(92)90432-71992277928Prognostic factors in nonmetastatic, favorable histology Wilms' tumor. Results of the third national Wilms' tumor studyDaniel M. Hays,
Pediatric Blood & Cancer10.1002/pbc.218092009522254-258Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology GroupConrad V. Fernandez, James Anderson, Norman E. Breslow, Jeffrey S. Dome, P.E. Grundy, Elizabeth J. Perlman, Daniel M. Green,,
Journal of Pediatric Surgery10.1053/jpsu.2000.69112000356891-89716q loss of heterozygosity and microsatellite instability in Wilms' tumorJohn E. Mason, Paul J. Goodfellow, Paul E. Grundy, Michael A. Skinner,
Medical and Pediatric Oncology10.1002/(sici)1096-911x(199603)26:3<147::aid-mpo1>;2-k1996263147-152Treatment of children with stage IV favorable histology Wilms tumor: A report from the National Wilms Tumor Study GroupDaniel M. Green, Norman E. Breslow, Ilonka Evans, Jami Moksness, Giulio J. D'Angio;2-K,;2-K
Journal of Pediatric Surgery10.1016/0022-3468(93)90476-2199328111515Treatment outcomes in patients less than two years of age with small, stage I, favorable-histology Wilms' tumors: A report from the national Wilms' tumor studyMichael P. Hirsh,
Pediatric Blood & Cancer10.1002/pbc.258402015634589-592Considerations in the Diagnosis and Management of Pediatric Patients With Favorable Histology Wilms Tumor Who Present With Only Pulmonary NodulesDaniel M. Green,,
Journal of Urology10.1016/j.juro.2012.09.00920131891260-267Loss of Heterozygosity Analysis at Different Chromosome Regions in Wilms Tumor Confirms 1p Allelic Loss as a Marker of Worse Prognosis: A Study from the Italian Association of Pediatric Hematology and OncologyFilippo Spreafico, Beatrice Gamba, Luigi Mariani, Paola Collini, Paolo D'Angelo, Andrea Pession, Andrea Di Cataldo, Paolo Indolfi, Marilina Nantron, Monica Terenziani, Carlo Morosi, Paolo Radice, Daniela Perotti,,,
Journal of Pediatric Surgery10.1016/s0022-3468(88)80518-91988235500Relapse associated variables in stage I. Favorable histology Wilms' tumorDaniel M. Hays,
Pediatric Blood & Cancer10.1002/pbc.241232012594631-635Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: A report from the Children's Oncology GroupPaul E. Grundy, Daniel M. Green, Astrid C. Dirks, Andrea E. Berendt, Norman E. Breslow, James R. Anderson, Jeffrey S. Dome,,